Zimmer Holdings, Inc. (ZMH) may have gone down swinging in its most recent courtroom drama with Stryker, but the orthopedics giant may be set to prop itself back up. The FDA gave the Warsaw, Ind.-based company 510(k) clearance for the Patient Specific Instrument Shoulder system. The clearance is to work hand-in-hand with another Zimmer device–the […]
Stryker Corp. (NYSE:SYK) filed a patent infringement lawsuit this week against Zimmer Holdings Inc. (NYSE:ZMH) over a trio of wound-care device patents. The lawsuit, filed in the U.S. District Court for Western New York, accuses Warsaw, Indiana-based Zimmer of violating the patents — “Irrigation handpiece with built in pulsing pump,” “Surgical/medical irrigator with removable tip […]
The U.S. Constitution's Commerce Clause states that Congress has the power to "regulate Commerce … among the several States." To supporters of health reform, the Commerce Clause is the Grinch that stole Obamacare, writes the Health Care Blog. To opponents, it might seem like a Sanity Clause.
The Food & Drug Administration warned Biomet Inc. that its personalized knee implant planning offering, the Signature Personalized Patient Care system, lacks approval or clearance to be on the market in the United States.
Highlights of the important and the interesting from the world of healthcare: Zimmer comes under federal microscope: Often a thorn in the side of the device and drug industries, Iowa Sen. Charles Grassley is reprising the role–and this time the target is Zimmer Holdings. Grassley has asked Indiana-based Zimmer to disclose how it tracked the […]
Tornier Inc. is planning to test the choppy waters of Wall Street with an estimated $205 million initial public offering, according to documents filed with the Securities and Exchange Commission. The orthopedics firm in Edina, Minn., which specializes in devices to treat injuries to extremities and small bones, is the third local medical device company […]
A specialty drug is a class of prescription medications used to treat complex, chronic or rare medical conditions. Although this classification was originally intended to define the treatment of rare, also termed “orphan” diseases, affecting fewer than 200,000 people in the US, more recently, specialty drugs have emerged as the cornerstone of treatment for chronic and complex diseases such as cancer, autoimmune conditions, diabetes, hepatitis C, and HIV/AIDS.
Zimmer Holdings Inc. (NYSE:ZMH) brought in a new president to lead its global business unit. Former Stryker Corp. (NYSE:SYK) executive Jeffrey Paulsen will lead the Warsaw, Ind.-based orthopedics giant's international operations.
